Cytokines in Health and Disease

What Are Cytokines?

"Cytokines are the principal means of communication among the cells of the immune system." - Cellular and Molecular Immunology, 10e

Classification of Cytokines

• Proinflammatory: TNF-α, IL-1, IL-6, IL-17
• Anti-inflammatory: IL-10, TGF-β, IL-4
• Th1-type: IFN-γ, IL-12, TNF-β - drive cellular immunity
• Th2-type: IL-4, IL-5, IL-13 - drive humoral/allergic immunity
• Th17-type: IL-17A, IL-17F, IL-22 - mucosal defense and autoimmunity

General Properties

• Pleiotropy: One cytokine acts on many different cell types
• Redundancy: Multiple cytokines share overlapping functions
• Synergy: Two cytokines together produce a greater effect than either alone
• Antagonism: One cytokine can inhibit another's effects
• Cascade induction: One cytokine triggers production of others, amplifying responses
• Short-lived signals: Most are produced transiently, only during active stimulation

Cytokines in Normal Physiology (Health)

1. Innate Immune Defense

• TNF-α - triggers the acute inflammatory cascade; increases endothelial adhesion molecules; activates neutrophil recruitment; at high systemic concentrations causes fever, hypotension, and coagulopathy
• IL-1β - acts synergistically with TNF-α; induces fever via prostaglandin E2 in the hypothalamus; stimulates acute-phase protein production in the liver
• IL-6 - drives the acute phase response (CRP, fibrinogen, SAA); promotes B cell differentiation into plasma cells; stimulates megakaryocyte maturation
• IL-12 - bridges innate and adaptive immunity; drives naïve T cells toward the Th1 phenotype; activates NK cells

"The cytokines of innate immunity serve several roles: inducing inflammation, inhibiting viral replication, promoting T cell responses, and limiting innate immune responses." - Cellular and Molecular Immunology, 10e

2. Shaping Adaptive Immune Responses: T Helper Subsets

• IL-12 + IFN-γ → Th1 cells (produce IFN-γ) → activate macrophages, kill intracellular pathogens (Mycobacterium, Leishmania)
• IL-4 → Th2 cells (produce IL-4, IL-5, IL-13) → IgE production, eosinophil activation, helminth defense
• TGF-β + IL-6 (+ IL-23 for maintenance) → Th17 cells (produce IL-17A/F, IL-22) → neutrophil recruitment, mucosal barrier defense against fungi/extracellular bacteria
• TGF-β → Treg cells (produce IL-10, TGF-β) → suppress excessive immune activation and maintain self-tolerance

"The particular cocktail of cytokines elaborated by DCs during the initial round of T-cell stimulation in a lymph node influences whether the response will be dominated by Th1 or Th2 cells." - Roitt's Essential Immunology

3. Macrophage Polarization

• M1 macrophages (classically activated by IFN-γ + LPS): high TNF-α, IL-12, IL-6 - kill pathogens
• M2 macrophages (alternatively activated by IL-4, IL-13): produce IL-10, TGF-β - tissue repair and resolution

4. Antiviral Defense

• Induce an antiviral state in surrounding cells (upregulate RNase L, PKR)
• Upregulate MHC class I on all nucleated cells, enhancing CTL recognition
• Activate NK cells to kill virally infected cells before adaptive responses develop

Cytokines in Disease

1. Cytokine Storm (Systemic Hyperinflammation)

• Sepsis (gram-negative endotoxin, gram-positive superantigens)
• Severe viral infections (SARS-CoV-2, influenza H5N1, SARS)
• Graft-versus-host (GVH) disease
• CAR-T cell therapy

• Systemic vasodilation and vascular leak
• Disseminated intravascular coagulation (DIC)
• Multi-organ failure
• Fever, shock, and potentially death

"Large amounts of TNF-α are produced during cytokine storms. TNF-α can promote inflammatory processes such as enhanced vascular leakage and activation of neutrophils that... on a systemic level will lead to fever, chills, aches, stimulation of coagulation pathways, elevated liver enzymes, loss of appetite, enhanced metabolism, weight loss, increased vascular permeability, and potentially shock." - Medical Microbiology, 9e

2. Autoimmune Diseases

3. Infectious Diseases

• Septic shock: TNF-α is the primary mediator; IL-1, IL-6 amplify the response; large TNF-α doses can recapitulate the features of gram-negative septic shock in animal models
• COVID-19 severe disease: Marked by elevated IL-6, IL-1β, IFN-γ, CXCL10 - forming the basis for IL-6 receptor blockade (tocilizumab) as therapy
• HIV/AIDS: Chronic immune activation with elevated TNF-α, IL-6, IL-1β even when viral load is suppressed
• Tuberculosis: IFN-γ from Th1 cells is essential for macrophage activation and granuloma formation; IL-12 deficiency or IL-12Rβ1 mutations → susceptibility to mycobacteria

4. Allergic and Atopic Disease

• IL-4: Switches B cells to produce IgE; drives mast cell and eosinophil recruitment
• IL-5: Master regulator of eosinophil production and survival
• IL-13: Promotes mucus hypersecretion, airway hyperresponsiveness (asthma)
• Therapeutic targets: dupilumab (anti-IL-4Rα, blocks IL-4 and IL-13) for atopic dermatitis/asthma; mepolizumab (anti-IL-5) for eosinophilic asthma

5. Cancer

• Cytokines in the tumor microenvironment (TME) are generally immunosuppressive: TGF-β, IL-10 suppress CTLs; VEGF promotes angiogenesis
• IFN-γ from tumor-infiltrating lymphocytes (TILs) is protective and correlates with better prognosis
• IL-6 drives tumor-associated cachexia, STAT3-mediated proliferation, and resistance to apoptosis
• Cytokines are also weaponized therapeutically (see below)

6. Neuropsychiatric Disease

• IL-1β, IL-6, TNF-α cross the blood-brain barrier and drive sickness behavior (fatigue, anorexia, social withdrawal, depression-like symptoms)
• Elevated proinflammatory cytokines are found in depression, schizophrenia, and neurodegenerative conditions (Alzheimer's, Parkinson's)
• Neuroinflammation in MS is propagated by IFN-γ and TNF-α, which damage oligodendrocytes and neurons at high concentrations

7. Genetic Cytokine Deficiencies

Cytokines as Therapeutic Targets

Cytokine Antagonists in Clinical Use

"The first clinically successful cytokine antagonists targeted TNF and included a soluble form of the TNF receptor and anti-TNF antibodies... These agents are of great benefit in many patients with rheumatoid arthritis, Crohn's disease, and psoriasis." - Cellular and Molecular Immunology, 10e

Cytokines as Therapeutics

• IL-2 (high-dose): Approved for metastatic melanoma and renal cell carcinoma; limited by vascular leak syndrome from downstream TNF/IFN-γ
• IFN-α: Approved for malignant melanoma, hairy cell leukemia, chronic myelogenous leukemia, AIDS-related Kaposi sarcoma, and hepatitis B/C (historical)
• G-CSF / GM-CSF: Used to shorten chemotherapy-induced neutropenia; stimulate neutrophil production after bone marrow transplant
• Erythropoietin: Treats anemia of chronic disease/CKD via cytokine-like action on erythroid progenitors

Summary Diagram (Conceptual)

PATHOGEN / TISSUE INJURY
        ↓
  PAMPs/DAMPs detected by macrophages, DCs
        ↓
  TNF-α, IL-1β, IL-6, IL-12 released
  ↙          ↓           ↘
Fever       Acute phase   Adaptive immune
vascular    response       response priming
leak        (liver: CRP)   (T helper subset
                           differentiation)
     ↓                       ↙   ↓   ↘
[Controlled] → Resolution   Th1  Th2  Th17
[Uncontrolled] → Cytokine   IFN-γ IL-4 IL-17
                  storm ↓
               Septic shock / MOF

Key Takeaways

1. Cytokines are the language of the immune system - produced rapidly in response to danger signals and acting locally and systemically to orchestrate defense.
2. The balance between pro- and anti-inflammatory cytokines determines whether inflammation resolves (health) or persists/escalates (disease).
3. T helper subset differentiation is driven by the local cytokine milieu - Th1/Th2/Th17/Treg imbalances underlie most immune-mediated diseases.
4. TNF-α, IL-1β, and IL-6 are the "master proinflammatory triad" - they drive the acute phase response, fever, and organ damage in sepsis.
5. Cytokine biology has transformed medicine: biologic drugs targeting cytokine pathways now treat rheumatological, dermatological, oncological, and GI diseases.
6. Genetic defects in specific cytokine pathways reveal which cytokines are non-redundant in vivo (e.g., IL-17 for fungal defense, IL-12 for mycobacterial defense, IL-10 for gut homeostasis).

• Cellular and Molecular Immunology, 10e (Abbas, Lichtman, Pillai)
• Roitt's Essential Immunology (Roitt)
• Medical Microbiology, 9e (Murray)
• Janeway's Immunobiology, 10e
• Recent reviews: Cytokine storm pathogenesis and treatment (Signal Transduct Target Ther, 2025, PMID 40234407); Interferons in health and disease (Cell, 2025, PMID 40845809)